AIDS and cancer in the era of highly active antiretroviral therapy (HAART)
- 1 July 2001
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 37 (10) , 1316-1319
- https://doi.org/10.1016/s0959-8049(01)00104-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- AIDS across Europe, 1994–98: the EuroSIDA studyThe Lancet, 2000
- Incidence and Trends in Kaposi's Sarcoma in the Era of Effective Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversionAIDS, 2000
- AIDS-Related Opportunistic Illnesses Occurring After Initiation of Potent Antiretroviral TherapyJAMA, 1999
- Changes in AIDS-Defining Illnesses in a London Clinic, 1987–1998JAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort studyBMJ, 1999
- Cancer Death Rates Associated With Human Immunodeficiency Virus Infection in the United StatesJNCI Journal of the National Cancer Institute, 1998
- Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral TherapyJAMA, 1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Trends in the Incidence of Outcomes Defining Acquired Immunodeficiency Syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985–1991American Journal of Epidemiology, 1993